In a recent series of cases, the Court of Appeals for the Federal Circuit (CAFC) evaluated whether examples in a patent specification will support infringement of alternative embodiments. Two recent ...
Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision. Lee (Harness IP): This is actually a huge-stakes case because this case discusses one of the most ...
Early this spring, in Hoffmann-La Roche, Inc. v. Promega, the United States Court of Appeals for the Federal Circuit reviewed a district court opinion on the validity of an issued patent 1. The court ...
Is it possible to patent biotech and pharmaceutical inventions globally using just one specification? John T Callahan and Ken Sakurabayashi of Sughrue Mion PLLC examine practice in the US, Japan and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results